FOLLOW US

  • facebook
  • twitter
Fri

March 20, 2026

Waters to combine with BD

America July 14, 2025

Waters, BD Unite in $17.5B Diagnostics Deal

In a strategic play poised to reshape the diagnostics and life sciences landscape, Waters Corp. and Becton Dickinson and Co.…

By Rihem Akkouche

AbbVie $2B Licensing Agreement

America July 10, 2025

AbbVie Strikes $2B Licensing Deal with IGI Therapeutics

In a move that signals intensifying ambitions in the cancer therapeutics arena, pharmaceutical titan AbbVie Inc. unveiled Thursday a blockbuster…

By Rihem Akkouche

Draig Therapeutics $140M Financing

America June 18, 2025

Draig Therapeutics Secures $140M Series A

Draig Therapeutics Ltd., a rising star in neuropsychiatric drug development, has closed a $140 million Series A financing round, the…

By Rihem Akkouche

Supernus to acquire Sage Therapeutics

America June 16, 2025

Supernus to Acquire Sage Therapeutics in $795M Deal

In a bold bid to dominate the neuropsychiatric treatment space, Supernus Pharmaceuticals Inc. announced Monday that it will acquire Sage…

By Rihem Akkouche

BioNTech To acquire CureVac

America June 12, 2025

BioNTech to Acquire CureVac in $1.25B Deal

In a bold move that could redefine the future of mRNA-driven cancer therapies, German biotech giant BioNTech SE announced Thursday…

By Rihem Akkouche

National Resilience filed for Chapter 11

America June 10, 2025

National Resilience Filed for Chapter 11

In a dramatic twist in the biotech sector, a subsidiary of National Resilience Holdco Inc. has filed for Chapter 11…

By Rihem Akkouche

Sanofi To Buy Blueprint Medicines

America June 2, 2025

Sanofi To Buy Blueprint Medicines For $9.5B

In a bold stride toward strengthening its grip on the immunology and rare disease market, French pharmaceutical titan Sanofi SA…

By Rihem Akkouche

Accelerate Diagnostics files for Chapter 11

America May 8, 2025

Accelerate Diagnostics files for Chapter 11

In a dramatic turn for the embattled biotech sector, Accelerate Diagnostics, Inc. has voluntarily filed for Chapter 11 bankruptcy protection in…

By Rihem Akkouche

Merck $2B China Cardio Drug Bet

America March 25, 2025

Merck Makes Bold $2B Bet on Chinese Cardio Drug

Merck & Co. Inc. is making a high-stakes move in the cardiovascular drug market, announcing on Tuesday an exclusive licensing…

By Rihem Akkouche

23AndMe Files for bankruptcy

America March 24, 2025

DNA testing firm 23andMe files for bankruptcy

23andMe Inc., once a trailblazer in consumer DNA testing, has filed for Chapter 11 bankruptcy protection in Missouri court, marking…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter